Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort.

Santos García D, de Deus Fonticoba T, Suárez Castro E, Borrué C, Mata M, Solano Vila B, Cots Foraster A, Álvarez Sauco M, Rodríguez Pérez AB, Vela L, Macías Y, Escalante S, Esteve P, Reverté Villarroya S, Cubo E, Casas E, Arnaiz S, Carrillo Padilla F, Pueyo Morlans M, Mir P, Martinez-Martin P; Coppadis Study Group.

Parkinsonism Relat Disord. 2019 Jul 29. pii: S1353-8020(19)30351-7. doi: 10.1016/j.parkreldis.2019.07.031. [Epub ahead of print]

PMID:
31409572
2.

Discussing sexuality with Parkinson's disease patients: a multinational survey among neurologists.

de Rooy FBB, Buhmann C, Schönwald B, Martinez-Martin P, Rodriguez-Blazquez C, Putter H, Elzevier HW, van der Plas AA.

J Neural Transm (Vienna). 2019 Aug 8. doi: 10.1007/s00702-019-02053-5. [Epub ahead of print]

PMID:
31396705
3.

Features and impact of missing values in the association of self-rated health with mortality in care homes: a longitudinal study.

Rodríguez-García MDP, Ayala A, Rodríguez-Blázquez C, Martínez-Martín P, Forjaz MJ, Damián J.

Health Qual Life Outcomes. 2019 Jun 29;17(1):111. doi: 10.1186/s12955-019-1184-z.

4.

Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer.

Matarazzo M, Arroyo-Gallego T, Montero P, Puertas-Martín V, Butterworth I, Mendoza CS, Ledesma-Carbayo MJ, Catalán MJ, Molina JA, Bermejo-Pareja F, Martínez-Castrillo JC, López-Manzanares L, Alonso-Cánovas A, Rodríguez JH, Obeso I, Martínez-Martín P, Martínez-Ávila JC, de la Cámara AG, Gray M, Obeso JA, Giancardo L, Sánchez-Ferro Á.

Mov Disord. 2019 Jun 18. doi: 10.1002/mds.27772. [Epub ahead of print]

PMID:
31211469
5.

COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation.

Santos García D, Jesús S, Aguilar M, Planellas LL, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, López Díaz L, Puente V, García Moreno JM, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Menéndez González M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues-Boixar O, González Ardura J, Prieto Jurczynska C, Martinez-Martin P, Mir P; COPPADIS Study Group.

Eur J Neurol. 2019 Jun 9. doi: 10.1111/ene.14008. [Epub ahead of print]

PMID:
31179586
6.

Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.

Evans AH, Okai D, Weintraub D, Lim SY, O'Sullivan SS, Voon V, Krack P, Sampaio C, Post B, Leentjens AFG, Martinez-Martin P, Stebbins GT, Goetz CG, Schrag A; Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee.

Mov Disord. 2019 Jun;34(6):791-798. doi: 10.1002/mds.27689. Epub 2019 May 28. Review.

PMID:
31136681
7.

Validation study of the Parkinson's Fatigue Scale in advanced Parkinson's disease.

Martinez-Martin P, Wetmore JB, Arbelo JM, Catalán MJ, Valldeoriola F, Rodriguez-Blazquez C.

Patient Relat Outcome Meas. 2019 Apr 17;10:141-152. doi: 10.2147/PROM.S196042. eCollection 2019.

8.

The Parkinson's Disease Sleep Scale-2 (PDSS-2): Validation of the Spanish Version and Its Relationship With a Roommate-Based Version.

Martinez-Martin P, Wetmore JB, Rodríguez-Blázquez C, Arakaki T, Bernal O, Campos-Arillo V, Cerda C, Estrada-Bellmann I, Garretto N, Ginsburg L, Máñez-Miró JU, Martínez-Castrillo JC, Pedroso I, Serrano-Dueñas M, Singer C, Rodríguez-Violante M, Vivancos F.

Mov Disord Clin Pract. 2019 Mar 18;6(4):294-301. doi: 10.1002/mdc3.12749. eCollection 2019 Apr.

PMID:
31061837
9.

Psychometric Properties of the Apathy Scale in Advanced Parkinson's Disease.

Wetmore JB, Arbelo JM, Catalán MJ, Valldeoriola F, Rodriguez-Blazquez C, Martinez-Martin P.

Parkinsons Dis. 2019 Mar 28;2019:1965394. doi: 10.1155/2019/1965394. eCollection 2019.

10.

Extensive validation study of the Parkinson's Disease Composite Scale.

Martinez-Martin P, Radicati FG, Rodriguez Blazquez C, Wetmore J, Kovacs N, Ray Chaudhuri K, Stocchi F; PDCS European Study Group.

Eur J Neurol. 2019 Apr 25. doi: 10.1111/ene.13976. [Epub ahead of print]

PMID:
31021043
11.

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson's disease.

van Wamelen DJ, Leta V, Podlewska AM, Wan YM, Krbot K, Jaakkola E, Martinez-Martin P, Rizos A, Parry M, Metta V, Ray Chaudhuri K.

J Neurol. 2019 Jul;266(7):1736-1742. doi: 10.1007/s00415-019-09325-w. Epub 2019 Apr 17.

12.

Pilot Study of the International Parkinson and Movement Disorder Society-sponsored Non-motor Rating Scale (MDS-NMS).

Martinez-Martin P, Schrag A, Weintraub D, Rizos A, Rodriguez-Blazquez C, Chaudhuri KR; IPMDS Non Motor PD Study Group.

Mov Disord Clin Pract. 2019 Feb 5;6(3):227-234. doi: 10.1002/mdc3.12728. eCollection 2019 Mar.

PMID:
30949554
13.

Influencing factors when living with Parkinson's disease: A cross-sectional study.

Ambrosio L, Portillo MC, Rodriguez-Blazquez C, Rojo JM, Martinez-Martin P; EC-PC Validation Group.

J Clin Nurs. 2019 Sep;28(17-18):3168-3176. doi: 10.1111/jocn.14868. Epub 2019 May 13.

PMID:
30938889
14.

The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.

Vizcarra JA, Sánchez-Ferro Á, Maetzler W, Marsili L, Zavala L, Lang AE, Martinez-Martin P, Mestre TA, Reilmann R, Hausdorff JM, Dorsey ER, Paul SS, Dexheimer JW, Wissel BD, Fuller RLM, Bonato P, Tan AH, Bloem BR, Kopil C, Daeschler M, Bataille L, Kleiner G, Cedarbaum JM, Klucken J, Merola A, Goetz CG, Stebbins GT, Espay AJ; MDS Technology Task Force and the MDS Rating Scales Program Electronic Development Ad-Hoc Committee.

Mov Disord. 2019 May;34(5):676-681. doi: 10.1002/mds.27673. Epub 2019 Mar 22. No abstract available.

PMID:
30901492
15.

Rapid UHPLC-MS metabolite profiling and phenotypic assays reveal genotypic impacts of nitrogen supplementation in oats.

Allwood JW, Xu Y, Martinez-Martin P, Palau R, Cowan A, Goodacre R, Marshall A, Stewart D, Howarth C.

Metabolomics. 2019 Mar 12;15(3):42. doi: 10.1007/s11306-019-1501-x.

16.

Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson's disease.

van Wamelen DJ, Podlewska AM, Leta V, Śmiłowska K, Rizos A, Martinez-Martin P, Bloem BR, Chaudhuri KR.

Parkinsonism Relat Disord. 2019 Jun;63:73-76. doi: 10.1016/j.parkreldis.2019.02.041. Epub 2019 Feb 28.

PMID:
30867088
17.

Minimal Clinically Important Difference for UPDRS-III in Daily Practice.

Sánchez-Ferro Á, Matarazzo M, Martínez-Martín P, Martínez-Ávila JC, Gómez de la Cámara A, Giancardo L, Arroyo Gallego T, Montero P, Puertas-Martín V, Obeso I, Butterworth I, Mendoza CS, Catalán MJ, Molina JA, Bermejo-Pareja F, Martínez-Castrillo JC, López-Manzanares L, Alonso-Cánovas A, Herreros Rodríguez J, Gray M.

Mov Disord Clin Pract. 2018 Jun 26;5(4):448-450. doi: 10.1002/mdc3.12632. eCollection 2018 Jul-Aug. No abstract available.

18.

Facility ownership and mortality among older adults residing in care homes.

Damián J, Pastor-Barriuso R, García-López FJ, Ruigómez A, Martínez-Martín P, de Pedro-Cuesta J.

PLoS One. 2019 Mar 1;14(3):e0197789. doi: 10.1371/journal.pone.0197789. eCollection 2019.

19.

Independent and Complementary Validation of the QUIP-RS in Advanced Parkinson's Disease.

Martinez-Martin P, Rodriguez-Blazquez C, Catalan MJ; EDIS Study Group.

Mov Disord Clin Pract. 2018 Mar 23;5(3):341-342. doi: 10.1002/mdc3.12603. eCollection 2018 May-Jun. No abstract available.

20.

Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease.

Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR & MDS Non‐Motor PD Study Group.

Mov Disord Clin Pract. 2018 Nov 8;6(1):57-64. doi: 10.1002/mdc3.12694. eCollection 2019 Jan.

PMID:
30746417
21.

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.

Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.

PMID:
30719763
22.

Reliability and Validity of Fall Efficacy Scale-International in People with Parkinson's Disease during On- and Off-Drug Phases.

Mehdizadeh M, Martinez-Martin P, Habibi SA, Fereshtehnejad SM, Abasi A, Niazi Khatoon J, Saneii SH, Taghizadeh G.

Parkinsons Dis. 2019 Jan 2;2019:6505232. doi: 10.1155/2019/6505232. eCollection 2019.

23.

Dietary Variations in a Multiethnic Parkinson's Disease Cohort and Possible Influences on Nonmotor Aspects: A Cross-Sectional Multicentre Study.

Sauerbier A, Schrag A, Martinez-Martin P, Hall LJ, Parry M, Mischley LK, Zis P, Chaudhuri KR.

Parkinsons Dis. 2018 Dec 18;2018:7274085. doi: 10.1155/2018/7274085. eCollection 2018.

24.

The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States.

Martinez-Martin P, Macaulay D, Jalundhwala YJ, Mu F, Ohashi E, Marshall T, Sail K.

Mov Disord. 2019 Feb;34(2):236-245. doi: 10.1002/mds.27579. Epub 2018 Dec 27.

25.

Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS.

Sharon D, Allen RP, Martinez-Martin P, Walters AS, Ferini Strambi L, Högl B, Trotti LM, Buchfuhrer M, Swieca J, Bogan RK, Zak R, Hensley JG, Schaefer LA, Marelli S, Zucconi M, Stefani A, Holzknecht E, Olvera V, Meaklim H, Laska I, Becker PM; International RLS Study Group.

Sleep Med. 2019 Feb;54:94-100. doi: 10.1016/j.sleep.2018.10.014. Epub 2018 Oct 29.

PMID:
30529783
26.

Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Pavy-Le Traon A, Cotterill N, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Tison F, Wenning GK, Goetz CG, Poewe W, Sampaio C, Schrag A, Rascol O, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Oct 25;5(5):479-491. doi: 10.1002/mdc3.12636. eCollection 2018 Sep-Oct. Review.

PMID:
30515437
27.

Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.

Mestre TA, Busse M, Davis AM, Quinn L, Rodrigues FB, Burgunder JM, Carlozzi NE, Walker F, Ho AK, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 May 9;5(4):361-372. doi: 10.1002/mdc3.12617. eCollection 2018 Jul-Aug.

28.

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study.

Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommée E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P.

Mov Disord Clin Pract. 2018 Mar 23;5(3):265-272. doi: 10.1002/mdc3.12607. eCollection 2018 May-Jun.

29.

Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.

Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the Movement Disorder Society Committee on Rating Scales Development.

Mov Disord Clin Pract. 2018 Jan 3;5(2):111-117. doi: 10.1002/mdc3.12571. eCollection 2018 Mar-Apr.

30.

Evaluation of nocturnal hypokinesia in Parkinson's disease using a novel patient/proxy questionnaire and correlations with objective monitoring.

Bhidayasiri R, Phokaewvarangkul O, Sringean J, Martinez-Martin P, Anan C, Kantachadvanich N, Chaudhuri KR, Hattori N.

Parkinsonism Relat Disord. 2019 Apr;61:219-223. doi: 10.1016/j.parkreldis.2018.09.023. Epub 2018 Sep 21.

PMID:
30314847
31.

Psychometric properties of the Berg balance scale in idiopathic Parkinson' disease in the drug off-phase.

Taghizadeh G, Martinez-Martin P, Fereshtehnejad SM, Habibi SA, Nikbakht N, Alizadeh NH, Salehi S, Mehdizadeh M.

Neurol Sci. 2018 Dec;39(12):2175-2181. doi: 10.1007/s10072-018-3570-4. Epub 2018 Sep 22.

PMID:
30244299
32.

Reply: Hoehn and Yahr stage 3 and Postural stability item in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Skorvanek M, Martinez-Martin P, Stebbins GT, Goetz CG.

Mov Disord. 2018 Jul;33(7):1189-1190. doi: 10.1002/mds.27452. No abstract available.

PMID:
30153386
33.

Validation of a simple screening tool for early diagnosis of advanced Parkinson's disease in daily practice: the CDEPA questionnaire.

Martinez-Martin P, Kulisevsky J, Mir P, Tolosa E, García-Delgado P, Luquin MR.

NPJ Parkinsons Dis. 2018 Jul 2;4:20. doi: 10.1038/s41531-018-0056-2. eCollection 2018.

34.

Rating Scales for Movement Disorders With Sleep Disturbances: A Narrative Review.

Rodríguez-Blázquez C, Forjaz MJ, Kurtis MM, Balestrino R, Martinez-Martin P.

Front Neurol. 2018 Jun 7;9:435. doi: 10.3389/fneur.2018.00435. eCollection 2018. Review.

35.

A detailed clinical study of pain in 1957 participants with early/moderate Parkinson's disease.

Silverdale MA, Kobylecki C, Kass-Iliyya L, Martinez-Martin P, Lawton M, Cotterill S, Chaudhuri KR, Morris H, Baig F, Williams N, Hubbard L, Hu MT, Grosset DG; UK Parkinson's Pain Study Collaboration.

Parkinsonism Relat Disord. 2018 Nov;56:27-32. doi: 10.1016/j.parkreldis.2018.06.001. Epub 2018 Jun 6.

36.

A Review of Scales to Evaluate Sleep Disturbances in Movement Disorders.

Kurtis MM, Balestrino R, Rodriguez-Blazquez C, Forjaz MJ, Martinez-Martin P.

Front Neurol. 2018 May 29;9:369. doi: 10.3389/fneur.2018.00369. eCollection 2018. Review.

37.

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR and MDS Non-motor PD Study Group.

Eur J Neurol. 2018 Oct;25(10):1255-1261. doi: 10.1111/ene.13691. Epub 2018 Jun 22.

PMID:
29806962
38.

Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.

Dafsari HS, Weiß L, Silverdale M, Rizos A, Reddy P, Ashkan K, Evans J, Reker P, Petry-Schmelzer JN, Samuel M, Visser-Vandewalle V, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):867-874. doi: 10.1016/j.brs.2018.02.015. Epub 2018 Feb 24.

PMID:
29655587
39.

Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.

Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, Ashkan K, Weis L, Dembek TA, Samuel M, Rizos A, Silverdale M, Barbe MT, Fink GR, Evans J, Martinez-Martin P, Antonini A, Visser-Vandewalle V, Timmermann L; EUROPAR; IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):904-912. doi: 10.1016/j.brs.2018.03.009. Epub 2018 Mar 16.

PMID:
29655586
40.

Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients.

Skorvanek M, Martinez-Martin P, Kovacs N, Zezula I, Rodriguez-Violante M, Corvol JC, Taba P, Seppi K, Levin O, Schrag A, Aviles-Olmos I, Alvarez-Sanchez M, Arakaki T, Aschermann Z, Benchetrit E, Benoit C, Bergareche-Yarza A, Cervantes-Arriaga A, Chade A, Cormier F, Datieva V, Gallagher DA, Garretto N, Gdovinova Z, Gershanik O, Grofik M, Han V, Kadastik-Eerme L, Kurtis MM, Mangone G, Martinez-Castrillo JC, Mendoza-Rodriguez A, Minar M, Moore HP, Muldmaa M, Mueller C, Pinter B, Poewe W, Rallmann K, Reiter E, Rodriguez-Blazquez C, Singer C, Valkovic P, Goetz CG, Stebbins GT.

Parkinsonism Relat Disord. 2018 Jul;52:83-89. doi: 10.1016/j.parkreldis.2018.03.027. Epub 2018 Mar 28.

PMID:
29625875
41.

Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.

Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2018 May;33(5):742-749. doi: 10.1002/mds.27317. Epub 2018 Mar 23. Review.

42.

Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.

Catalan MJ, Molina-Arjona JA, Mir P, Cubo E, Arbelo JM, Martinez-Martin P; EDIS Study Group.

J Neurol. 2018 Jun;265(6):1279-1287. doi: 10.1007/s00415-018-8803-1. Epub 2018 Mar 20.

PMID:
29557989
43.

Pain in Parkinson's disease: facts and uncertainties.

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O.

Eur J Neurol. 2018 Jul;25(7):917-e69. doi: 10.1111/ene.13624. Epub 2018 Apr 18. Review.

PMID:
29520899
44.

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.

Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2018 Mar;33(3):421-430. doi: 10.1002/mds.27283. Epub 2018 Feb 21.

PMID:
29465787
45.

Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect.

Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P.

Mov Disord. 2018 Mar;33(3):499-500. doi: 10.1002/mds.27339. Epub 2018 Feb 20. No abstract available.

PMID:
29460975
46.

Validation study of the hoehn and yahr scale included in the MDS-UPDRS.

Martinez-Martin P, Skorvanek M, Rojo-Abuin JM, Gregova Z, Stebbins GT, Goetz CG; members of the QUALPD Study Group.

Mov Disord. 2018 Apr;33(4):651-652. doi: 10.1002/mds.27242. Epub 2018 Jan 11. No abstract available.

PMID:
29322548
47.

Rating scales for cognition in Huntington's disease: Critique and recommendations.

Mestre TA, Bachoud-Lévi AC, Marinus J, Stout JC, Paulsen JS, Como P, Duff K, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2018 Feb;33(2):187-195. doi: 10.1002/mds.27227. Epub 2017 Dec 26. Review.

PMID:
29278291
48.

Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease.

Dafsari HS, Reker P, Silverdale M, Reddy P, Pilleri M, Martinez-Martin P, Rizos A, Perrier E, Weiß L, Ashkan K, Samuel M, Evans J, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non-Motor PD Study Group.

Neuromodulation. 2018 Aug;21(6):532-540. doi: 10.1111/ner.12740. Epub 2017 Dec 20.

PMID:
29266613
49.

Non motor symptoms in progressive supranuclear palsy: prevalence and severity.

Radicati FG, Martinez Martin P, Fossati C, Chaudhuri KR, Torti M, Rodriguez Blazquez C, Vacca L, Stocchi F.

NPJ Parkinsons Dis. 2017 Dec 8;3:35. doi: 10.1038/s41531-017-0037-x. eCollection 2017.

50.

The Parkinson's Disease Composite Scale: results of the first validation study.

Stocchi F, Radicati FG, Chaudhuri KR, Johansson A, Padmakumar C, Falup-Pecurariu C, Martinez-Martin P.

Eur J Neurol. 2018 Mar;25(3):503-511. doi: 10.1111/ene.13529. Epub 2018 Jan 13.

PMID:
29193455

Supplemental Content

Loading ...
Support Center